http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011073907-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f284b17a359324d427ab2e3b3ac26c75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9414eb8baa5e3ff1d70c9b21b4cdb1ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_efead86e4208e7117f7aca61754bdea3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_979a139ea45c14ba193f5cd431fd2290
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3b87b47407d929b7852321461253c5fa
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14
filingDate 2010-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e1d4189b5677404a1cb66046292d5fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6adf02f5d5412a995c446916249adca5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb135781cfd7ab09751d20c9fc578de6
publicationDate 2011-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2011073907-A1
titleOfInvention A polymorph form of nevirapine and its preparation
abstract The invention relates to a metastable unsolvated crystalline form (Form- IV) of nevirapine, having at least one characteristic x-ray powder diffraction peak at approximately 7.1 ° to 7.5° two theta. The invention further relates to a preparation method of producing a particulate anhydrous unsolvated form of nevirapine.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013039987-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9273049-B2
priorityDate 2009-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005059653-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006183738-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007010352-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5366972-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9909990-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410579
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66971432
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4463
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227495804
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395530
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128738613
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15910

Total number of triples: 34.